Sema4 Holdings Corp
NASDAQ:SMFR
Sema4 Holdings Corp
Cash & Cash Equivalents
Sema4 Holdings Corp
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Sema4 Holdings Corp
NASDAQ:SMFR
|
Cash & Cash Equivalents
$123.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
DaVita Inc
NYSE:DVA
|
Cash & Cash Equivalents
$345.1m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-11%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash & Cash Equivalents
$474m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
0%
|
CAGR 10-Years
13%
|
|
CVS Health Corp
NYSE:CVS
|
Cash & Cash Equivalents
$9.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Cigna Corp
NYSE:CI
|
Cash & Cash Equivalents
$8.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash & Cash Equivalents
$99.3m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-12%
|
See Also
What is Sema4 Holdings Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
123.9m
USD
Based on the financial report for Dec 31, 2022, Sema4 Holdings Corp's Cash & Cash Equivalents amounts to 123.9m USD.
What is Sema4 Holdings Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 1Y
-69%
Over the last year, the Cash & Cash Equivalents growth was -69%.